Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116363
Status:
UNKNOWN
Last Update Posted:
2008-04-01
First Post:
2005-06-28
Brief Title:
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Sponsor:
Introgen Therapeutics
Organization:
Introgen Therapeutics
Organization Data
Organization:
Introgen Therapeutics
Class:
INDUSTRY
Study ID:
INT 241-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Introgen Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| MD Anderson Cancer Center | OTHER |